Form D — Vitalis Therapeutics, Inc.
0000929638-25-000820 · filed 2025-02-19
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $3,004,968
- Total sold
- $1,954,956
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vitalis Therapeutics, Inc.
- CIK
- 2026886
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 93 4TH AVENUE, #19
NEW YORK, NY 10003 - Phone
- 646-831-7338
Related persons
-
Joseph Habboushe · DirectorNew York, NY Find on LinkedIn ↗
View original on SEC EDGAR.